ARCHIVES

Efaproxyn Improved Survival Of Patients With Brain Mets

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

NCI-Approved Cancer Center, Cooperative Group Trials

December 28, 2007

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

Broder’s Conundrum: How To Let Congress Know NCI Needs More Money Without Asking For it

March 17, 1989

Trials Approved by NCI CTEP For the Month of March

March 30, 2012